Adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers
Molly B. El Alam(The University of Texas MD Anderson Cancer Center), Lauren E. Colbert(The University of Texas MD Anderson Cancer Center), Melissa P. Mezzari(Baylor College of Medicine), Nadim J. Ajami(Baylor College of Medicine), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), Lilie L. Lin(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Anuja Jhingran(The University of Texas MD Anderson Cancer Center), Joseph Abi Jaoude(The University of Texas MD Anderson Cancer Center), Xiaogang Wu(The University of Texas MD Anderson Cancer Center), Travis T. Sims(The University of Texas MD Anderson Cancer Center), Patricia J. Eifel(The University of Texas MD Anderson Cancer Center), Greyson Biegert(The University of Texas MD Anderson Cancer Center), Andrea Y. Delgado Medrano(The University of Texas MD Anderson Cancer Center), Ramez Kouzy(The University of Texas MD Anderson Cancer Center), Mustapha Ahmed-Kaddar(The University of Texas MD Anderson Cancer Center), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), Kathleen M. Schmeler(The University of Texas MD Anderson Cancer Center), Tatiana V. Karpinets(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Kyoko Yoshida-Court(The University of Texas MD Anderson Cancer Center), Travis Solley(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k